|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|6450341||1415995||2017||6 صفحه PDF||سفارش دهید||دانلود رایگان|
- Synthetic scaffold complex strategy is proposed for enhancement of GABA production.
- Glutamate decarboxylase and GABA transporter was co-localized via scaffold complex.
- GABA production is increased by 3.5 fold via synthetic scaffold complex.
- E. coli mutant strain XBT, obtained 98% of GABA yield.
Gamma-aminobutyric acid (GABA) is a precursor to pyrrolidone, a monomer used for the production of a biodegradable polymer known as nylon-4. GABA is also widely used in the medical industry to treat conditions such as high blood pressure, anxiety and depression. Generally, GABA is produced from glutamate by the enzyme glutamate decarboxylase (GadB). In this study, a synthetic scaffold complex was introduced between Pyrococcus horikoshii GadB and the GABA antiporter (GadC) from E. coli. P. horikoshii GadB was attached to the N-terminus, C-terminus and middle of E. coli GadC via scaffolding. Among the three scaffold complexes evaluated, the N-terminus scaffold model produced 5.93Â g/L of GABA from 10Â g/L monosodium glutamate (MSG). When the gabT mutant E. coli XBT strain was used, the highest GABA concentration of 5.96Â g/L was obtained, which is 97.8% of GABA yield. In addition to GABA concentration, GABA productivity was increased 3.5 fold via the synthetic scaffold complex.
Journal: Biochemical Engineering Journal - Volume 120, 15 April 2017, Pages 1-6